CAS 65002-17-7: bucillamine
Description:Bucillamine is a synthetic compound primarily used as a disease-modifying antirheumatic drug (DMARD) in the treatment of rheumatoid arthritis. It is classified as a thiol-containing compound, which contributes to its mechanism of action by modulating immune responses and exhibiting anti-inflammatory properties. Bucillamine is known for its ability to reduce joint inflammation and damage associated with autoimmune conditions. The substance has a relatively low molecular weight and is soluble in water, which facilitates its absorption and bioavailability in the body. Its chemical structure includes a dithiol moiety, which is significant for its reactivity and therapeutic effects. Bucillamine is generally well-tolerated, but like any medication, it may have side effects, including gastrointestinal disturbances and potential liver toxicity. Monitoring is essential during treatment to manage any adverse reactions. Overall, bucillamine represents an important option in the pharmacological management of chronic inflammatory diseases.
Formula:C7H13NO3S2
InChI:InChI=1S/C7H13NO3S2/c1-7(2,13)6(11)8-4(3-12)5(9)10/h4,12-13H,3H2,1-2H3,(H,8,11)(H,9,10)/t4-/m0/s1
InChI key:InChIKey=VUAFHZCUKUDDBC-BYPYZUCNSA-N
SMILES:O=C(O)C(NC(=O)C(S)(C)C)CS
- Synonyms:
- (2R)-2-(2-Methyl-2-sulfanylpropanamido)-3-sulfanylpropanoic acid
- (R)-3-Mercapto-2-(2-mercapto-2-methylpropanamido)propanoic acid
- <span class="text-smallcaps">L</span>-Cysteine, N-(2-mercapto-2-methyl-1-oxopropyl)-
- De 019
- N-(2-Mercapto-2-methyl-1-oxopropyl)-<span class="text-smallcaps">L</span>-cysteine
- N-(2-Mercapto-2-methylpropanoyl)-<span class="text-smallcaps">L</span>-cysteine
- N-(2-Mercapto-2-methylpropionyl)-<span class="text-smallcaps">L</span>-cysteine
- N-(2-Mercaptoisobutyryl)cysteine
- N-(2-methyl-2-sulfanylpropanoyl)-L-cysteine
- N-(2-methyl-2-sulfanylpropanoyl)cysteine
- See more synonyms
- Rimatil
- Sa 96
- Thiobutarit
- Tiobutarit
